MD Anderson And Xilis Announce Strategic Collaboration To Advance Novel Technology And Accelerate Therapeutic Development
February 16, 2023
February 16, 2023
HOUSTON, Texas, Feb. 16 (TNSpar) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Feb. 15, 2023:
The University of Texas MD Anderson Cancer Center and Xilis today announced a strategic collaboration to deploy Xilis' proprietary MicroOrganoSphere(TM) (MOS) technology in support of preclinical research to accelerate the development of novel cancer therapies.
Under the agreement, the two organizations aim to advance drug developme . . .
The University of Texas MD Anderson Cancer Center and Xilis today announced a strategic collaboration to deploy Xilis' proprietary MicroOrganoSphere(TM) (MOS) technology in support of preclinical research to accelerate the development of novel cancer therapies.
Under the agreement, the two organizations aim to advance drug developme . . .